Tumor microenvironment evaluation to predict anti-PD-1 response of advanced gastric cancer: Results from a multicenter prospective clinical trial.

被引：0
|
作者：
Liao, Wangjun
Shi, Min
Zeng, Dongqiang
Luo, Huiyan
Xiao, Jian
Ye, Feng
Xiong, Hailin
Yuan, Xia
Huang, Yisheng
Li, Yongqiang
Huang, Na
Wu, Jianhua
Li, Shaowei
Zheng, Siting
Wu, Jiani
Sun, Li
Rong, Xiaoxiang
Wang, Chunlin
Guo, Jian
Deng, Qiong
机构：
[1] Southern Med Univ, Nanfang Hosp, Dept Oncol, Guangzhou, Peoples R China
[2] Sun Yat sen Univ, Canc Ctr, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Med Oncol, Guangzhou, Peoples R China
[4] Xiamen Univ, Dept Med Oncol, Affiliated Hosp 1, Xiamen, Peoples R China
[5] Huizhou First Hosp, Dept Med Oncol, Huizhou, Peoples R China
[6] Maoming Peoples Hosp, Dept Oncol, Maoming, Peoples R China
[7] Guangxi Med Univ, Dept Med Oncol, Canc Hosp, Nanning, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
415
引用
收藏
页码：415 / 415
页数：1
相关论文
共 50 条
  • [1] Tumor microenvironment evaluation and tumor intrinsic genomic features predict anti-PD-1 response of metastatic gastric cancer: Results from phase II clinical trial and multi-omics data
    Zeng, Dongqiang
    Liao, Wangjun
    Kim, Kyoung Mee
    Shi, Min
    Zhou, Rui
    Yu, Yunfang
    Ye, Zilan
    Wu, Jiani
    CANCER RESEARCH, 2020, 80 (16)
  • [2] Tumor microenvironment evaluation to predict pembrolizumab benefit of metastatic gastric cancer: Results from phase II clinical trial
    Zeng, Dongqiang
    Liao, Wangjun
    Shi, Min
    Zhou, Rui
    Huang, Na
    Yu, Yunfang
    Peng, Wenying
    Wu, Jiani
    Ye, Zilan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [3] Tumor immune microenvironment characterization and response to anti-PD-1 therapy
    Santarpia, Mariacarmela
    Karachaliou, Niki
    CANCER BIOLOGY & MEDICINE, 2015, 12 (02) : 74 - 78
  • [4] Tumor immune microenvironment characterization and response to anti-PD-1 therapy
    Mariacarmela Santarpia
    Niki Karachaliou
    Cancer Biology & Medicine, 2015, (02) : 74 - 78
  • [5] Tumor immune microenvironment characterization and response to anti-PD-1 therapy
    Mariacarmela Santarpia
    Niki Karachaliou
    Cancer Biology & Medicine, 2015, 12 (02) : 74 - 78
  • [6] MFSD2A potentiates gastric cancer response to anti-PD-1 immunotherapy by reprogramming the tumor microenvironment to activate T cell response
    Zhang, Bin
    Wang, Chun-Mei
    Wu, Hao-Xiang
    Wang, Feng
    Chai, Yang-Yang
    Hu, Ye
    Wang, Bing-Jing
    Yu, Zhou
    Xia, Rong-Hua
    Xu, Rui-Hua
    Cao, Xue-Tao
    CANCER COMMUNICATIONS, 2023, 43 (10) : 1097 - 1116
  • [7] Tumor-intrinsic response to IFNγ shapes the tumor microenvironment and anti-PD-1 response in NSCLC
    Bullock, Bonnie L.
    Kimball, Abigail K.
    Poczobutt, Joanna M.
    Neuwelt, Alexander J.
    Li, Howard Y.
    Johnson, Amber M.
    Kwak, Jeff W.
    Kleczko, Emily K.
    Kaspar, Rachael E.
    Wagner, Emily K.
    Hopp, Katharina
    Schenk, Erin L.
    Weiser-Evans, Mary C. M.
    Clambey, Eric T.
    Nemenoff, Raphael A.
    LIFE SCIENCE ALLIANCE, 2019, 2 (03)
  • [8] Tumor radiomic features on pretreatment MRI to predict response to lenvatinib plus an anti-PD-1 antibody in advanced hepatocellular carcinoma: a multicenter study
    Xu, Bin
    Dong, Sanyuan
    Bai, Xue-Li
    Song, Tian-Qiang
    Zhang, Bo-Heng
    Zhou, Le-Du
    Chen, Yong-Jun
    Zeng, Zhi-Ming
    Wang, Kui
    Zhao, Hai-Tao
    Lu, Na
    Zhang, Wei
    Li, Xu-Bin
    Zheng, Su-Su
    Long, Guo
    Yang, Yu-Chen
    Huang, Hua-Sheng
    Huang, Lan-Qing
    Wang, Yun-Chao
    Liang, Fei
    Zhu, Xiao-Dong
    Huang, Cheng
    Shen, Ying-Hao
    Zhou, Jian
    Zeng, Meng-Su
    Fan, Jia
    Rao, Sheng-Xiang
    Sun, Hui-Chuan
    LIVER CANCER, 2023, 12 (03) : 262 - 276
  • [9] G1s-010, a novel anti-PD-1 mAb in Chinese advanced gastrointestinal tumor: Result of a phase Ib clinical trial.
    Lin, Shen
    Gong, Jifang
    Xu, Yingying
    Zhang, Xiaotian
    Peng, Zhi
    Qi, Changsong
    Li, Guochun
    Meng, Haijin
    Liu, Zhen
    Wang, Hui
    Chen, Chris
    Li, Jing
    Zheng, Yong
    Lee, Johnathan
    Zhang, Yan
    Zhang, Qiang
    Jin, Ge
    Yang, Yining
    Zhao, Guodong
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [10] Efficacy and safety of sintilimab (anti-PD-1 mAb) for advanced cervical cancer: Results from a Phase II trial
    Gao, Qinglei
    Wang, Jing
    Xu, Qin
    Tang, Ying
    Zhang, Jieqing
    Chang, Baoping
    Xia, Bairong
    Duan, Wei
    Wang, Danbo
    Zhu, Lijing
    An, Ruifang
    Zhang, Guonan
    Tang, Yaling
    Huang, Jianli
    Zhang, Xiang
    Qiu, Hui
    Ji, Wenting
    Li, Li
    Zhu, Jianqing
    Ma, Ding
    CANCER RESEARCH, 2023, 83 (08)
12345